Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.
- NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_assertion description "[The depletion of B cells by anti-CD20/19 monoclonal antibody Retuximab� used in autoimmune diseases therapy leads to systemic side effects and should be significantly improved.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.
- NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_assertion evidence source_evidence_literature NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.
- NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_assertion SIO_000772 21677771 NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.
- NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_assertion wasDerivedFrom befree-20140225 NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.
- NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_assertion wasGeneratedBy ECO_0000203 NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.
- befree-20140225 importedOn "2014-02-25" NP911350.RAc6fUdYSXBCLfQ0R_HEWIIPNePatjH5620z4XZqtiv1o130_provenance.